WEDNESDAY, March 24, 2021 (HealthDay News) — In utero exposure to 17α-hydroxyprogesterone caproate (17-OHPC) is associated with an increased risk for any cancer in adult offspring, according to a study presented at the annual meeting of The Endocrine Society, held virtually from March 20 to 23. Caitlin C. Murphy, Ph.D., M.P.H., from the University of...